PHI with Urinary calculus
How does this condition affect your private health insurance?
Harnkonkremente, commonly known as kidney stones or urinary calculi, are hard deposits made of minerals and salts that form inside the kidneys. They can develop anywhere in the urinary tract, from the kidneys to the bladder. Symptoms typically include severe pain (renal colic) often in the back or side, radiating to the groin, accompanied by nausea, vomiting, blood in the urine, and frequent, painful urination. Causes can range from dehydration and dietary factors to metabolic disorders and genetic predisposition. Treatment varies from pain management and increased fluid intake to medical expulsion therapy or surgical procedures like lithotripsy or ureteroscopy for larger or symptomatic stones. Early diagnosis and management are crucial to prevent complications like infection or kidney damage.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 15%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically hours to a few days for acute renal colic, though stone passage can take days to weeks.
Duration of Illness (Lifetime)
Often a recurrent condition; individuals have a 50% chance of recurrence within 5-10 years if underlying causes are not addressed.
Cost of Treatment (Initial)
Moderate to high, typically $500 - $15,000 depending on diagnostic needs and intervention type.
Cost of Treatment (Lifetime)
Potentially very high, especially for recurrent cases requiring multiple interventions and long-term metabolic workup, potentially exceeding $20,000-$50,000.
Mortality Rate
Extremely low (<0.1%), usually only in cases of severe, untreated infection (urosepsis) or bilateral obstruction leading to kidney failure.
Risk of Secondary Damages
Moderate (10-30%) for complications like urinary tract infections, hydronephrosis (kidney swelling), kidney damage if obstruction is prolonged, or chronic pain.
Probability of Full Recovery
High (80-90%) for the current episode with appropriate treatment, but recurrence rates are significant (50% within 5-10 years).
Underlying Disease Risk
Moderate (20-40%) for metabolic disorders (e.g., hyperparathyroidism, gout, renal tubular acidosis), anatomical abnormalities, or genetic predispositions.